Apolipoprotein may have potential protective role in paediatric sepsis
Sepsis characterized by dysregulation of body's response to infection stands as the main cause of mortality in children.Despite the numerous clinical trials conducted, the quest for effective drugs to combat sepsis remains an immensely challenging undertaking.
Apolipoprotein H (APOH), also known as beta-2-glycoprotein I (β2-GPI), is a highly abundant plasma protein with a molecular size of approximately 50 kDa. It is primarily synthesized by liver cells and comprises five domains (I–V).It is a critical plasma protein that plays a crucial role in regulating various biological processes. However, its precise role in the immunopathology of paediatric sepsis remains unclear.
Recent research paper investigates the potential role of Apolipoprotein H (APOH) in pediatric sepsis. The study evaluated the concentration of APOH in pediatric patients with sepsis and healthy individuals, and the impact of APOH on survival, organ injury, and inflammation in a clinically relevant sepsis model induced by caecal ligation and puncture (CLP). The findings indicated that APOH levels were decreased in patients with sepsis compared to healthy controls, and lower APOH levels were associated with higher mortality rates. Additionally, the therapeutic intervention with recombinant APOH protein lowered the mortality rate, mitigated organ injury, and suppressed inflammation in mice with severe sepsis. In contrast, neutralizing APOH with an anti-APOH monoclonal antibody increased the mortality rate and exacerbated organ injury. The study also demonstrated that APOH inhibited M1 polarization in macrophages by suppressing the toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway, without directly affecting bacterial burden, neutrophil, and macrophage counts. The authors concluded that APOH has a protective role in the host defense response to sepsis and highlighted its potential therapeutic value in sepsis treatment. This study provides valuable insights into the potential role of APOH in modulating the immunopathology of pediatric sepsis and the underlying molecular mechanisms.
Reference –
Yu, Z., Xiao, C., Liu, R. et al. The protective effect of apolipoprotein H in paediatric sepsis. Crit Care 28, 36 (2024). https://doi.org/10.1186/s13054-024-04809-2
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.